tiprankstipranks
Corbus Pharmaceuticals (CRBP)
NASDAQ:CRBP
US Market
CRBP
Corbus Pharmaceuticals
RESEARCH TOOLSreports

Corbus Pharmaceuticals (CRBP) Financial Statements

Compare
2,541 Followers

Corbus Pharmaceuticals Financial Overview

Corbus Pharmaceuticals's market cap is currently $154.48M. The company's EPS TTM is $-1.25; its P/E ratio is -1.38; Corbus Pharmaceuticals is scheduled to report earnings on March 9, 2026, and the estimated EPS forecast is $-1.20. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 881.71K
Gross Profit$ -233.00K$ -600.00K$ 0.00$ -1.49M$ -757.53K
Operating Income$ -85.31M$ -48.72M$ -45.08M$ -34.84M$ -55.99M
EBITDA$ -85.08M$ -37.74M$ -40.10M$ -38.73M$ -54.35M
Net Income$ -78.54M$ -40.21M$ -44.60M$ -55.83M$ -45.55M
Balance Sheet
Cash & Short-Term Investments$ 28.49M$ 149.06M$ 20.91M$ 59.20M$ 97.65M
Total Assets$ 168.19M$ 155.88M$ 28.27M$ 66.31M$ 107.73M
Total Debt$ 1.63M$ 3.24M$ 20.89M$ 25.09M$ 26.59M
Net Debt$ -26.86M$ -13.96M$ 7.16M$ 8.09M$ 1.58M
Total Liabilities$ 20.69M$ 13.45M$ 35.18M$ 33.32M$ 38.62M
Stockholders' Equity$ 147.50M$ 142.43M$ -6.91M$ 32.99M$ 69.11M
Cash Flow
Free Cash Flow$ -64.50M$ -41.79M$ -36.10M$ -37.56M$ -48.24M
Operating Cash Flow$ -64.49M$ -41.79M$ -36.10M$ -37.54M$ -48.18M
Investing Cash Flow$ -1.64M$ -121.31M$ 35.64M$ 30.07M$ -73.42M
Financing Cash Flow$ 77.43M$ 166.58M$ -2.82M$ -533.62K$ 60.82M
Currency in USD

Corbus Pharmaceuticals Earnings and Revenue History

Income Statement >

Corbus Pharmaceuticals Debt to Assets

Balance Sheet >

Corbus Pharmaceuticals Cash Flow

Cash Flow >

Corbus Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >